Cargando…

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus

BACKGROUND: The risk of cardiovascular disease (CVD) in diabetes mellitus (DM) patients is two- to three-fold higher than in the general population. We designed a 10-year cohort trial in T2DM patients to explore the performance of QRESEARCH risk estimator version 3 (QRISK3) as a CVD risk assessment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Xiaodie, Wu, Aihua, Hu, Huiyue, Zhou, Hua, Yang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742415/ https://www.ncbi.nlm.nih.gov/pubmed/36518244 http://dx.doi.org/10.3389/fendo.2022.1077632

Ejemplares similares

Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
por: Mu, Xiaodie, et al.
Publicado: (2023)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022)

QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021)

Predictors of Cardiovascular Autonomic Neuropathy in Patients with Type 1 Diabetes
por: Tannus, Lucianne Righeti Monteiro, et al.
Publicado: (2014)

Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links
por: De Rosa, Salvatore, et al.
Publicado: (2018)

Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus
por: Zhao, Shuo, et al.
Publicado: (2021)

Cardiovascular risk quantification using QRISK-3 score in people with intellectual disability
por: Ho, Jamie Sin Ying, et al.
Publicado: (2021)

The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events
por: Kassem, Mahmoud Attia Mohamed, et al.
Publicado: (2017)

Fracture risk assessment in diabetes mellitus
por: Chen, Weiwei, et al.
Publicado: (2022)

Impact of Baseline and Trajectory of Triglyceride-Glucose Index on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus
por: Tai, Shi, et al.
Publicado: (2022)

Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus
por: Lv, Ruolin, et al.
Publicado: (2023)

QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
por: Edwards, Nicola, et al.
Publicado: (2018)

Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease
por: Li, Chengshun, et al.
Publicado: (2022)

Ten-Year Cardiovascular Risk as Predicted by the QRISK®3 Calculator in Diabetic Patients Attending a Tertiary Care Teaching Hospital in Central India and Its Application to Stratify Statin Over-Users and Under-Users
por: Chandrawanshi, Varnan, et al.
Publicado: (2023)

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus
por: Saleem, Fatima
Publicado: (2017)

SAT-545 Diabetes Mellitus Is the Risk Factor of Cardiovascular and Cerebrovascular Events in Primary Aldosteronism
por: Otsuki, Michio, et al.
Publicado: (2020)

The Association Between Acylcarnitine Metabolites and Cardiovascular Disease in Chinese Patients With Type 2 Diabetes Mellitus
por: Zhao, Shuo, et al.
Publicado: (2020)

Cardiovascular Magnetic Resonance as Pathophysiologic Tool in Diabetes Mellitus
por: Mavrogeni, Sophie I., et al.
Publicado: (2021)

Predictors of Mortality Subsequent to a Fracture in Diabetes Mellitus Patients
por: Westberg-Rasmussen, Sidse, et al.
Publicado: (2015)

Cardiovascular Autonomic Neuropathy Contributes to Sleep Apnea in Young and Lean Type 1 Diabetes Mellitus Patients
por: Janovsky, Carolina Castro Porto Silva, et al.
Publicado: (2014)

Triglyceride−glucose index in the prediction of major adverse cardiovascular events in patients with type 2 diabetes mellitus after coronary artery bypass surgery: A retrospective cohort study
por: Zhang, He, et al.
Publicado: (2022)

Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
por: Iwamoto, Yuichiro, et al.
Publicado: (2022)

Relationship between plasma glutamate and cardiovascular disease risk in Chinese patients with type 2 diabetes mellitus by gender
por: Li, Ru-Tao, et al.
Publicado: (2023)

History of Gestational Diabetes Mellitus in Relation to Cardiovascular Disease and Cardiovascular Risk Factors in US Women
por: Shostrom, Derrick C. V., et al.
Publicado: (2017)

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
por: Mu, Xiaodie, et al.
Publicado: (2022)

Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study
por: Yao, Xuelin, et al.
Publicado: (2023)

Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021)

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
por: Collins, Gary S, et al.
Publicado: (2009)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
por: Parsons, Ruth E, et al.
Publicado: (2023)

Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
por: Wan, Xin-Xing, et al.
Publicado: (2022)

Ankle-Brachial Index Is Independently Associated With Cardiovascular Outcomes and Foot Ulcers in Asian Patients With Type 2 Diabetes Mellitus
por: Yang, Ming-Chi, et al.
Publicado: (2021)

Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
por: Zhang, Chunye, et al.
Publicado: (2021)

Progression to type 2 diabetes mellitus after gestational diabetes mellitus diagnosed by IADPSG criteria: Systematic review and meta-analysis
por: Juan, Juan, et al.
Publicado: (2022)

Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio: A valuable predictor of type 2 diabetes mellitus incidence
por: Xie, Wangcheng, et al.
Publicado: (2022)

Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus
por: Wan, Shu-jun, et al.
Publicado: (2022)

Genomic DNA Methylation in Diabetic Chronic Complications in Patients With Type 2 Diabetes Mellitus
por: Wang, Xixi, et al.
Publicado: (2022)

Molecular and Cellular Events Mediating Glomerular Podocyte Dysfunction and Depletion in Diabetes Mellitus
por: Anil Kumar, P., et al.
Publicado: (2014)

Risk Assessment of Sarcopenia in Patients With Type 2 Diabetes Mellitus Using Data Mining Methods
por: Cui, Mengzhao, et al.
Publicado: (2020)

Establishment and validation of a clinical model for predicting diabetic ketosis in patients with type 2 diabetes mellitus
por: Qi, Mengmeng, et al.
Publicado: (2022)

Predictive nomogram model for major adverse kidney events within 30 days in sepsis patients with type 2 diabetes mellitus
por: Xin, Qi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p37akigbfd32p2udn8jpfqg1p2